Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI®) for the treatment of external ocular infections in dogs

Journal of Controlled Release

Volumn 85, Issue 1-3, 2002, Pages 163-168

  Baeyens, V ^a   Felt Baeyens, O ^a   Rougier, S ^b   Pheulpin, S ^b   Boisrame B ^b   Gurny, Robert ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Vétoquinol ^*  (France)

Author keywords

Bacterial infections; Clinical efficacy; Compliance; Dog; Gentamicin; Insert; Ocular drug delivery

Indexed keywords

AGENTS ACTING ON THE EYE; BODI; EYE DROPS; HUMISCREEN; OPTIMMUNE; TIACIL; ADHESIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CONJUNCTIVITIS; CONTROLLED STUDY; CONVALESCENCE; CORNEA ULCER; DOG DISEASE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; KERATOCONJUNCTIVITIS SICCA; MALE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; ANIMAL; ANIMAL DISEASE; BACTERIAL EYE INFECTION; COMPARATIVE STUDY; DOG; DRUG EFFECT; DRUG SCREENING; EYE; METHODOLOGY; MICROBIOLOGY;

ADHESIVES; ANIMALS; DOGS; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; EYE; EYE INFECTIONS, BACTERIAL; FEMALE; MALE; OPHTHALMIC SOLUTIONS;

EID: 0037073656     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00284-5     Document Type: Article

References (13)

1. Baeyens V., Percicot C.L., Zignani M., Deshpande A.A., Kaltsatos V., Gurny R. Ocular drug delivery in veterinary medicine. Adv. Drug Deliv. Rev. 28:1997;335-361.
2. Barnett K.C., Sansom J. Diagnosis and treatment of keratoconjunctivitis sicca in the dog. Vet. Rec. 120:1987;340-345.
3. Aguirre G.D. Keratoconjunctivitis sicca in dogs. J. Am. Vet. Med. Assoc. 158:1971;1566.
4. Kaswan R.L., Salisbury M.A., Lothrup C.D. Interaction of age and gender on occurrence of canine keratoconjunctivitis sicca. Proc. Vet. Comp. Ophthalmol. 1:1991;93-97.
5. Hakanson N., Forrester S.D. Uveitis in the dog and cat. Vet. Clin. North Am. Small Anim. Pract. 20:1990;715-735.
6. Gurtler F., Kaltsatos V., Boisramé B., Deleforge J., Gex-Fabry M., Balant L.P., Gurny R. Ocular availability of gentamicin in small animals after topical administration of a conventional eye drop solution and a novel long acting bioadhesive ophthalmic drug insert. Pharm. Res. 12:1995;1791-1795.
7. Miller G.K. Clinical evaluation of gentamicin in bacterial infections of the canine and feline eye. Vet. Med. Small Anim. Clin. 66:1971;492-495.
8. Martin C.L. Ocular infections. Greene C.E. Infectious Diseases of the Dog and Cat. 1990;197-212 W.B. Sauders, Philadelphia.
9. Baeyens V., Gurny R. Review: chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations. Pharm. Acta Helv. 72:1997;191-202.
10. Baeyens V., Kaltsatos V., Boisramé B., Fathi M., Gurny R. Evaluation of soluble ophthalmic inserts for prolonged release of gentamicin: lachrymal pharmacokinetics and ocular tolerance. J. Ocul. Pharmacol. Ther. 14:1997;263-272.
11. Gurtler F., Kaltsatos V., Boisramé B., Gurny R. Long-acting soluble Bioadhesive Ophthalmic Drug Insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigation. J. Control. Release. 33:1995;231-236.
12. Baeyens V., Kaltsatos V., Boisramé B., Varesio E., Veuthey J.-L., Fathi M., Balant L.P., Gex-Fabry M., Gurny R. Optimized release of dexamethasone and gentamicin from a soluble insert for the treatment of external ophthalmic infections. J. Control. Release. 52:1997;215-220.
13. Clerc B.G. Les conjonctivites. Clerc B.G. Ophtalmologie vétérinaire. 1981;124-139 Les éditions du point vétérinaire, Maisons-Alfort.